FILING ANALYSIS · WEDNESDAY, OCTOBER 7
Profound Medical Corp. PROF — 8-K: Results of Operations and Financial Condition
positive
Profound Medical Corp. reports preliminary Q3 revenue of $9.8-10.0 million, exceeding Bloomberg analyst consensus by 45-47% and representing 85-89% year-over-year growth. The company's strong commercial momentum and expected gross margin above 70% are key drivers of this growth.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →